Combat Diabetic Nephropathy: From Pathogenesis to Treatment

Combat Diabetic Nephropathy: From Pathogenesis to Treatment

Bibliographic Details
Main Authors:	Gohda, Tomohito, Mima, Akira, Moon, Ju-Young, Kanasaki, Keizo
Format:	Online
Language:	English
Published:	Hindawi Publishing Corporation 2014
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3972827/

Similar Items

Pathogenesis and Novel Treatment from the Mouse Model of Type 2 Diabetic Nephropathy
by: Furukawa, Masako, et al.
Published: (2013)

Lipid mediators in diabetic nephropathy
by: Srivastava, Swayam Prakash, et al.
Published: (2014)

The Role of Ubiquitination and Sumoylation in Diabetic Nephropathy
by: Gao, Chenlin, et al.
Published: (2014)

Role of Mindin in Diabetic Nephropathy
by: Murakoshi, Maki, et al.
Published: (2011)

MicroRNAs in Kidney Fibrosis and Diabetic Nephropathy: Roles on EMT and EndMT
by: Srivastava, Swayam Prakash, et al.
Published: (2013)

Diabetic nephropathy: the role of inflammation in fibroblast activation and kidney fibrosis
by: Kanasaki, Keizo, et al.
Published: (2013)

Combating Kidney Fibrosis
by: Kanasaki, Keizo, et al.
Published: (2014)

Pathogenesis of diabetic nephropathy
by: Cao, Zemin, et al.
Published: (2011)

Microinflammation in the pathogenesis of diabetic nephropathy
by: Shikata, Kenichi, et al.
Published: (2013)

Autophagy as a Therapeutic Target in Diabetic Nephropathy
by: Tanaka, Yuki, et al.
Published: (2012)

Sirtuins and renal diseases: relationship with aging and diabetic nephropathy
by: Kitada, Munehiro, et al.
Published: (2012)

N-acetyl-seryl-aspartyl-lysyl-proline: a valuable endogenous anti-fibrotic peptide for combating kidney fibrosis in diabetes
by: Kanasaki, Keizo, et al.
Published: (2014)

Inflammation and Oxidative Stress in Diabetic Nephropathy: New Insights on Its Inhibition as New Therapeutic Targets
by: Mima, Akira
Published: (2013)

The Role of Autophagy in the Pathogenesis of Diabetic Nephropathy
by: Yamahara, Kosuke, et al.
Published: (2013)

The Relevance of the Renin-Angiotensin System in the Development of Drugs to Combat Preeclampsia
by: Ueki, Norikazu, et al.
Published: (2015)

Role of Nutrient-Sensing Signals in the Pathogenesis of Diabetic Nephropathy
by: Kume, Shinji, et al.
Published: (2014)

Histone Acetylation and Its Modifiers in the Pathogenesis of Diabetic Nephropathy
by: Li, Xiaoxia, et al.
Published: (2016)

Complexity of diabetic nephropathy pathogenesis and design of investigations
by: Tavafi, Majid
Published: (2013)

Role of Nitric Oxide in the Pathogenesis of Diabetic Nephropathy in Streptozotocin-Induced Diabetic Rats
by: Choi, Ki Chul, et al.
Published: (1999)

Dietary Restriction Ameliorates Diabetic Nephropathy through Anti-Inflammatory Effects and Regulation of the Autophagy via Restoration of Sirt1 in Diabetic Wistar Fatty (fa/fa) Rats: A Model of Type 2 Diabetes
by: Kitada, Munehiro, et al.
Published: (2011)

Dipeptidyl peptidase-4 and kidney fibrosis in diabetes
by: Shi, Sen, et al.
Published: (2016)

Circulating TNF Receptors 1 and 2 Are Associated with the Severity of Renal Interstitial Fibrosis in IgA Nephropathy
by: Sonoda, Yuji, et al.
Published: (2015)

Diabetic nephropathy – complications and treatment
by: Lim, Andy KH
Published: (2014)

Mitochondrial reactive oxygen species in the pathogenesis of early diabetic nephropathy
by: Nishikawa, Takeshi, et al.
Published: (2015)

Cancer biology in diabetes
by: Sen, Shi, et al.
Published: (2014)

Diabetic angiopathy and angiogenic defects
by: Xu, Ling, et al.
Published: (2012)

Diabetic Retinopathy: From Pathogenesis to Treatment
by: Chakrabarti, Subrata
Published: (2007)

Incretin-Based Therapy for Prevention of Diabetic Vascular Complications
by: Mima, Akira
Published: (2016)

Beneficial effects of tonsillectomy plus steroid pulse therapy on inflammatory and tubular markers in patients with IgA nephropathy
by: Maruyama, Shuntaro, et al.
Published: (2016)

The Emerging Role of Pathogenesis of IgA Nephropathy
by: Meng-Yu Wu, et al.
Published: (2018-08-01)

The Role of Visfatin in Diabetic Nephropathy
by: Kang, Young Sun, et al.
Published: (2011)

Elevation of the antifibrotic peptide N-acetyl-seryl-aspartyl-lysyl-proline: a blood pressure-independent beneficial effect of angiotensin I-converting enzyme inhibitors
by: Kanasaki, Megumi, et al.
Published: (2011)

Non-diabetic nephropathy in diabetics
Published: (2014)

Diabetic Nephropathy without Diabetes
by: López-Revuelta, Katia, et al.
Published: (2015)

Effect of Astragalus membranaceus extract on diabetic nephropathy
by: Kim, Jiman, et al.
Published: (2014)

Diabetic nephropathy – Epidemiology in Asia and the current state of treatment
by: Ritz, E., et al.
Published: (2011)

Chinese medicines in the treatment of experimental diabetic nephropathy
by: Liu, Jing-Yi, et al.
Published: (2016)

Treatment of Hepatitis B Virus-Associated Membranous Nephropathy: Lamivudine Era versus Post-Lamivudine Era
by: Moon, Ju-Young, et al.
Published: (2012)

N-acetyl-seryl-aspartyl-lysyl-proline Inhibits Diabetes-Associated Kidney Fibrosis and Endothelial-Mesenchymal Transition
by: Nagai, Takako, et al.
Published: (2014)

Tubulointerstitial disease in diabetic nephropathy
by: Tonolo, Giancarlo, et al.
Published: (2014)